David J. Schlanger - 21 Apr 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Executive Chairman, Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
21 Apr 2023
Net transactions value
-$1,620,330
Form type
4
Filing time
25 Apr 2023, 16:58:56 UTC
Previous filing
05 Apr 2023
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $33,939 +37,296 +51% $0.9100* 110,783 21 Apr 2023 Direct
transaction PGNY Common Stock Sale $1,305,733 -37,296 -34% $35.01 73,487 21 Apr 2023 Direct F1, F2
transaction PGNY Common Stock Options Exercise $9,304 +10,224 +14% $0.9100* 83,711 24 Apr 2023 Direct
transaction PGNY Common Stock Sale $357,840 -10,224 -12% $35.00 73,487 24 Apr 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -37,296 -5.1% $0.000000 694,932 21 Apr 2023 Common Stock 37,296 $0.9100 Direct F4
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -10,224 -1.5% $0.000000 684,708 24 Apr 2023 Common Stock 10,224 $0.9100 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F4 These options are fully vested and exercisable.